Position in EOLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,153,376
New position
Shares Held
2,470,408
first reported quarter
Ownership
3.75%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VANGUARD CAPITAL MANAGEMENT LLC holds $8,602,483,583 across 56 Drug Manufacturers - Specialty & Generic names. EOLS ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
26,072,846 | $3,082,071,125 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,957,539 | $1,160,781,476 | |
| 3 | VTRS |
Viatris Inc
|
74,716,631 | $1,009,421,684 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
4,511,904 | $594,398,232 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
22,336,124 | $534,503,447 | |
| 6 | ALKS |
Alkermes plc.
|
7,427,397 | $262,632,757 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
2,914,314 | $221,050,716 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
9,339,711 | $193,892,400 |
All Filings in EOLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,153,376 | 2,470,408 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||